U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492836) titled 'Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma' on March 11.
Brief Summary: The goal of this clinical trial is to evaluate the feasibility, safety and effectiveness of radiotherapy with fewer days of treatment and a higher dose of radiation each day in patients under 70 years of age diagnosed with a brain tumor known as glioblastoma.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Glioblastoma (GBM)
Intervention:
RADIATION: Hypofractionated Radiation Therapy
60 Gy in 20 fractions of 3 Gy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Hospital do Cora...